Sellas' Reverse Merger Round

Sellas raised a round of funding on August 08, 2017. Investors include Galena Biopharma.

Sellas develops therapies for treating cancer. It is a late-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The comp…

Articles about Sellas' Reverse Merger Round: